ArticleSignal transduction and targeted therapy2024

Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease.

Zhenzhen Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.